Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178366 | SCV000230435 | likely benign | not specified | 2014-06-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000398505 | SCV000636627 | likely benign | Kleefstra syndrome 1 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314643 | SCV000849051 | likely benign | Inborn genetic diseases | 2018-01-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000398505 | SCV001137982 | likely benign | Kleefstra syndrome 1 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001706141 | SCV001855563 | benign | not provided | 2018-10-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001706141 | SCV004032915 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | EHMT1: BP4, BS1 |